Insulin lispro: Drug hypersensitivity: case report
Insulins are a class of drugs used to treat type 1 (T1DM) and type 2diabetes mellitus(T2DM). T1DM is a condition caused by anautoimmunereaction that destroys the beta cells of the pancreas because of which the body cannot produce or synthesizeinsulinneeded to manage circulating blood sugar le...
赖脯胰岛素 英文品名Insulin Lispro 名称来源p-INNList-72,1994;r-INNList-35,1995; 化学表述28B-L-lysine-29B-L-prolineinsulin (human) CA登记号133107-64-9 分子式C257H383N65O77S6 结构式 品种类别消化系统>抗糖尿病药>胰岛素类;
赖脯胰岛素笔式注射器(Insulin lispro) HUMALOG是一种速效人胰岛素类似物,可改善成人和儿童糖尿病患者的血糖控制。 海外直邮 药师指导 隐私服务 签订合同 别名: 赖脯胰岛素笔式注射器,Insulin lispro,Humalog,Liprolog 分类: 2型糖尿病 有效期: 24个月 ...
Insulin Aspart drug usage statistics for the United States (2013 - 2022). Statistics include drug synonyms and therapeutic classes, including: Insulin Aspart Recombinant, Insulin Aspart, Fiasp, Fiasp Flextouch, Fiasp Penfill, Novolog, Novolog Flexpen, No
List of Drug Master Files (DMF) of Insulin Lispro Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website
Rapid-acting insulins are a class of drugs used to control high blood sugar in people with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) along with a proper diet and exercise.
5.1.1.2 Levemir (Insulin Detemir) 5.1.1.3 Toujeo (Insulin Glargine) 5.1.1.4 Tresiba (Insulin Degludec) 5.1.1.5 Basaglar (Insulin Glargine) 5.1.2 Bolus or Fast Acting Insulins 5.1.2.1 NovoRapid/Novolog (Insulin Aspart) 5.1.2.2 Humalog (Insulin Lispro) 5.1.2.3 Apidra (Insulin Glulisine) 5.1...
Examples of DDIs in DrugBank only include acebutolol/Insulin Lispro and metronidazole/terfenadine. Examples of DDIs in NDF-RT only include amiodarone/sotalol and meperidine/linezolid. When we only consider DDIs from the reference set, the overlap between DrugBank and NDF-RT is significantly ...
AWARD 4 was a random, open level phase 3 trial, 52 week study conducted with Dulaglutide versus bed time insulin glargine both in combination with prandial insulin lispro in T2DM patients. The study for a time period of 52 weeks resulted in significant decrease in HbA1c, weight reduction and...